Cite
HARVARD Citation
Wang, Y. et al. (2022). BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System Involvement. Journal of immunotherapy. 45 (1), pp. 25-34. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, Y. et al. (2022). BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System Involvement. Journal of immunotherapy. 45 (1), pp. 25-34. [Online].